Page last updated: 2024-10-27

fluorouracil and Immune System Diseases

fluorouracil has been researched along with Immune System Diseases in 1 studies

Fluorouracil: A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the THYMIDYLATE SYNTHETASE conversion of deoxyuridylic acid to thymidylic acid.
5-fluorouracil : A nucleobase analogue that is uracil in which the hydrogen at position 5 is replaced by fluorine. It is an antineoplastic agent which acts as an antimetabolite - following conversion to the active deoxynucleotide, it inhibits DNA synthesis (by blocking the conversion of deoxyuridylic acid to thymidylic acid by the cellular enzyme thymidylate synthetase) and so slows tumour growth.

Immune System Diseases: Disorders caused by abnormal or absent immunologic mechanisms, whether humoral, cell-mediated, or both.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mendonça, MA1
Souto, FO1
Micheli, DC1
Alves-Filho, JC1
Cunha, FQ1
Murta, EF1
Tavares-Murta, BM1

Other Studies

1 other study available for fluorouracil and Immune System Diseases

ArticleYear
Mechanisms affecting neutrophil migration capacity in breast cancer patients before and after chemotherapy.
    Cancer chemotherapy and pharmacology, 2014, Volume: 73, Issue:2

    Topics: Actins; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Case-Control

2014